S&P 5007,659▼ 1.09%Nasdaq26,140▼ 2.15%Dow Jones52,002▼ 0.34%Nasdaq 10029,188▼ 2.50%VIX19.99▲ 21.45%US Dollar101.84▼ 0.21%Gold (GLD)382.01▼ 0.18%Oil (USO)161.76▲ 2.83%
Fair value lists · updated after every US close (16 Oct 2026)

Undervalued & overvalued stocks

Ranked by the gap to fair value — then sort by financial health, growth, debt, profitability or dividends to separate real bargains from value traps.

Most undervalued Most overvalued Undervalued + quality
Sort by Gap to fair value ↓ X-Ray Score Financial health Growth Lowest debt Profitability (ROIC) Dividend yield Piotroski F-Score
Then by
Only show ✓ Financial health ≥ 70 Low debt (< 1.5× EBITDA) Growth ≥ 50 Pays dividend ≥ 2% ✓ Piotroski ≥ 7

Most undervalued — US stocks

Sorted by Gap to fair value (high → low) · 8 shown of 8
$66.03$143.23
+117%
64
85
26
Net cash
17%
2.0%
8/9
UndervaluedMedium uncertainty · 30% margin
$75.93$156.82
+107%
65
88
48
Data missing
15%
0.1%
9/9
UndervaluedMedium uncertainty · 30% margin
$124.18$221.39
+78%
77
75
66
0.9×
31%
—
9/9
UndervaluedMedium uncertainty · 30% margin
$59.22$97.80
+65%
68
79
42
0.6×
22%
2.4%
8/9
UndervaluedMedium uncertainty · 30% margin
$256.29$398.57
+56%
55
77
29
1.0×
13%
0.9%
7/9
UndervaluedMedium uncertainty · 30% margin
$45.73$69.01
+51%
75
87
91
Data missing
35%
—
7/9
UndervaluedMedium uncertainty · 30% margin
$389.10$571.16
+47%
65
73
52
Data missing
13%
2.1%
8/9
UndervaluedMedium uncertainty · 30% margin
$43.50$63.57
+46%
66
76
67
5.6×
5%
3.8%
7/9
UndervaluedMedium uncertainty · 30% margin
Click any column to sort · 8 stocks in this listPage 1 of 1
Financial health (0–100)
Piotroski F-Score, Altman Z, interest cover, liquidity: ranked within sector.
Growth (0–100)
Revenue, EPS and free-cash-flow growth over the last three years.
Net debt / EBITDA
Years of earnings needed to repay debt. "Net cash" means more cash than debt.
ROIC
Return on invested capital: how efficiently the business earns profit.
Dividend yield
Trailing 12-month dividends ÷ price.
Piotroski F-Score (0–9)
9 accounting tests of profitability, leverage and efficiency.

Model estimates, not price targets or recommendations. For educational purposes only. Not financial advice.